Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: Bone Marrow Transplant. 2016 Feb 15;51(6):813–818. doi: 10.1038/bmt.2016.7

Figure 1.

Figure 1

Depiction of the transplant program with first pharmacological Preconditoning Therapy with ImmunoSuppressive drugs (PTIS), followed by reduced-toxicity conditioning with ATG, Fludarabine and IV Busulfan. For the haplo-identical donors we use post-Cy based GvHD prophylaxis and delayed calcineurin inhibitor-/ sirolimus therapy and short-course MMF, the latter two starting on day SCT +5. Please see Patients and Methods section for details.